Junyelt

Copper Gluconate, Manganese Gluconate, Potassium Iodide, Sodium Selenite, Zinc Gluconate, the active ingredients in Junyelt, are mineral supplements presented as an intravenous solution for intravenous use. They address trace element deficiencies and provide essential nutritional support for patients requiring parenteral nutrition.

GNH USA supplies Junyelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. Its supply chain adheres to stringent regulatory standards, facilitating consistent availability across diverse markets.

Junyelt is used to correct trace element deficiencies and support nutritional status in patients receiving parenteral nutrition. - Trace element deficiency: restores essential copper, manganese, iodine, selenium, and zinc levels. - Parenteral nutrition support: supplies required trace minerals for patients on intravenous feeding. - Critical care patients: helps maintain micronutrient balance during intensive therapy. - Post‑surgical recovery: contributes to wound healing by providing necessary trace elements. - Malabsorption disorders: offers an alternative route for mineral supplementation when oral absorption is impaired.

Junyelt may be associated with infusion‑related reactions and systemic mineral‑related adverse events.

Common Side Effects: - Infusion site pain or irritation - Mild nausea or vomiting - Transient headache - Metallic taste - Low‑grade fever - Mild skin rash

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction - Copper or zinc toxicity leading to hepatic dysfunction - Selenium overdose causing respiratory distress - Severe hypotension or arrhythmia - Acute renal impairment - Metabolic acidosis

Prior to administering Junyelt, clinicians should observe the following precautions. - Baseline assessment: evaluate serum trace element levels to identify deficiency. - Monitoring: regularly check copper, zinc, selenium, and iodine concentrations during therapy. - Organ function: use with caution in patients with hepatic or renal impairment. - Hypersensitivity: avoid in individuals with known allergy to any component. - Pregnancy and lactation: assess risk‑benefit ratio as safety data are limited. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Junyelt can interact with certain medications and supplements; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - High‑dose oral copper or zinc supplements: may cause mineral overload. - Chelating agents (e.g., penicillamine, dimercaprol): reduce effectiveness of administered trace elements. - Thyroid hormone therapy: excess iodine may alter hormone levels.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracyclines or quinolones: may bind divalent cations and affect absorption. - Diuretics (especially thiazides): can influence electrolyte balance and zinc excretion. - ACE inhibitors or ARBs: may potentiate changes in serum potassium and iodine handling.